Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
EWSR1-and FUS-rearranged acute leukemias: Clinicopathological and genomic characterization.
Journal: Human pathology
Published: September 14, 2025
Factors associated with and kinetics of anti-IFN-α autoantibodies in RAG1/2 deficiency.
Journal: The journal of allergy and clinical immunology. Global
Published: January 25, 2025
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Journal: British journal of haematology
Published: November 17, 2023
Diagnosis and management of mature B-cell lymphomas in children, adolescents, and young adults.
Journal: Best practice & research. Clinical haematology
Published: March 20, 2023
Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV.
Journal: Journal of pediatric hematology/oncology
Published: November 24, 2019
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Journal: British journal of haematology
Published: August 18, 2018
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.
Journal: Oncoimmunology
Published: April 25, 2018
Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.
Journal: British journal of haematology
Published: February 28, 2018
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.
Journal: British journal of haematology
Published: August 31, 2016
Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.
Journal: British journal of haematology
Published: March 22, 2016
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.
Journal: British journal of haematology
Published: December 09, 2014
Last Updated: 09/26/2026